Page last updated: 2024-08-23

isosorbide-5-mononitrate and Atherogenesis

isosorbide-5-mononitrate has been researched along with Atherogenesis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimura, N; Hidaka, T; Higashi, Y; Kajikawa, M; Kihara, Y; Liao, JK; Maruhashi, T; Matsumoto, T; Nakashima, A; Noma, K1
Garaliene, V1

Reviews

1 review(s) available for isosorbide-5-mononitrate and Atherogenesis

ArticleYear
[Endothelium and nitric oxide].
    Medicina (Kaunas, Lithuania), 2008, Volume: 44, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Endothelium, Vascular; Homeostasis; Humans; Hypolipidemic Agents; Isosorbide Dinitrate; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Vasodilator Agents

2008

Trials

1 trial(s) available for isosorbide-5-mononitrate and Atherogenesis

ArticleYear
Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2015, Volume: 38, Issue:7

    Topics: Aged; Aged, 80 and over; Angina Pectoris; Atherosclerosis; Biomarkers; Female; Humans; Isosorbide Dinitrate; Leukocytes; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Prospective Studies; rho-Associated Kinases

2015